Literature DB >> 3498147

Evidence for a two-site model of forskolin action in frog urinary bladder.

M Svelto, V Casavola, G Valenti, J Bourguet.   

Abstract

In the present study several aspects of the osmotic water-flow-regulation mechanism in frog urinary bladder were examined, utilizing forskolin either as a direct hydrosmotic agent or in association with vasopressin. It was found that forskolin induces a hydrosmotic effect similar to the one induced by vasopressin. This effect is rapid, reversible and dose-dependent. The half-maximally effective concentration (Ec50FSK) is 1.37 microM forskolin. No additional effect on the osmotic water flow was observed when maximal concentrations of forskolin and vasopressin were given simultaneously. Moreover, forskolin can also markedly potentiate vasopressin-induced hydrosmotic response. This potentiation was maximal with submaximal doses of vasopressin, whereas it disappeared when the hormonal concentration was increased to very high levels. Therefore, forskolin increases vasopressin potency without affecting vasopressin efficacy. The Ec50FSK for the forskolin-induced increase in vasopressin potency was 11 nmol, about two orders of magnitude lower than the Ec50FSK for the direct effect of forskolin on the osmotic water transport. On the whole, our results are compatible with a two-site model of forskolin action in frog urinary bladder: a low affinity site (Ec50FSK = 1.37 microM) that mediates the direct action of forskolin on the osmotic water flow and a high affinity site (Ec50FSK = 11 nmol), which mediates the synergic effect of forskolin with the antidiuretic hormone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498147     DOI: 10.1007/BF00583805

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  21 in total

1.  [AN AUTOMATIC DEVICE FOR MEASURING AND RECORDING THE NET FLOW OF WATER THROUGH THE SKIN AND BLADDER OF AMPHIBIA].

Authors:  J BOURGUET; S JARD
Journal:  Biochim Biophys Acta       Date:  1964-09-25

Review 2.  Inositol phospholipids and cell surface receptor function.

Authors:  R H Michell
Journal:  Biochim Biophys Acta       Date:  1975-03-25

3.  Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.

Authors:  A M Siegl; J W Daly; J B Smith
Journal:  Mol Pharmacol       Date:  1982-05       Impact factor: 4.436

4.  Quantitation and early kinetics of inositol lipid changes induced by vasopressin in isolated and cultured hepatocytes.

Authors:  A P Thomas; J S Marks; K E Coll; J R Williamson
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

5.  Interaction of forskolin with dually regulated adenylate cyclase.

Authors:  K B Seamon; B Wetzel
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1984

6.  PGE2, forskolin, and cholera toxin interactions in modulating NaCl transport in mouse mTALH.

Authors:  R M Culpepper; T E Andreoli
Journal:  Am J Physiol       Date:  1984-11

Review 7.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981

8.  Forskolin mimics the hydrosmotic action of vasopressin in the urinary bladder of toads Bufo marinus.

Authors:  R C De Sousa; A Grosso
Journal:  J Physiol       Date:  1985-08       Impact factor: 5.182

9.  Regulation of [3H]forskolin binding to human platelet membranes by GppNHp, NaF, and prostaglandin E1.

Authors:  C A Nelson; K B Seamon
Journal:  FEBS Lett       Date:  1985-04-22       Impact factor: 4.124

10.  Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein.

Authors:  K Seamon; J W Daly
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.